Strategic focus Iaso Ventures is a Boston-based venture capital firm focused on early-stage brain health ventures and operates with an investor-operator team and strategic partner network, indicating opportunities to collaborate on portfolio companies and co-investment avenues.

Recent investments Recent activity includes a $39M Series A investment in Aerska, a CNS RNA medicines company, signaling appetite for brain health technologies and potential for co-investment, deal sourcing, or syndication opportunities.

Partnerships and fundraise Demonstrated collaboration with foundations and funds through Epilepsy Foundation partnership to establish the Iaso NeuroImpact Fund, presenting a potential for philanthropic-aligned ventures, grant opportunities, and strategic co-funding arrangements.

Operational capability The firm emphasizes operator-led support and venture studio experiences since 2020, suggesting value propositions around portfolio operations, talent acceleration, and go-to-market execution services for early-stage brain-health startups.

Technology footprint Utilizes a modern but compact tech stack (HubSpot Analytics, iCIMS, WordPress, Google Workspace, Lightbox, PHP, Piwik PRO Core, Apache) indicating potential for collaboration on martech, recruitment, analytics, and digital marketing enablement for startup clients.